Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 protein-coding genes, only about 4,500 are ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
Knowing when to try something new versus stick with what you’re doing is tricky. Decision scientists have advice.
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy.
Brain organoids reveal that two genetic mutations in DEPDC5 drive epilepsy, disrupting early brain development, and causing ...
We asked a Chicago-based food writer to recommend where to get the city's iconic hot dogs — this spot was the first (and only ...
See how Bambanker™ supports high post-thaw recovery and reliable downstream performance across tissues, organoids, tumor ...
Why does the same genetic mutation cause a severe brain malformation in some patients but not in others? Researchers from the ...
Horse racing's best rivalry resumes on Saturday when reigning Horse of the Year Sovereignty faces three-time Grade 1 winner ...
World class horse racing takes place at Keeneland Race Course in Lexington, Ky., and on Saturday there's a $3 late Pick 3 ...
ART IN THE SQUARE. FREE This juried art festival is bringing more than 140 artists from across the United States to Southlake ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results